IMPACT REPORT
2019
GOLD SPONSOR
SILVER SPONSORS
CHARGING POLE SPONSOR
WI-FI SPONSOR
LIVESTREAM SPONSOR
NETWORKING COFFEE BREAK SPONSOR
SUPPORTED BY
2019 Mexico is undergoing a demographic transition and an aging process. In 2000, the number of people aged 60 years and older represented 6.8 percent of the national population. This figure is expected to grow to 28 percent by 2050, according to the National Population Council. At the same time, obesity, cancer and heartrelated diseases remain the three main morbidities in the country and constitute a challenge for the health system, providers and payers.
The sum of all epidemiological and demographic factors creates significant challenges for the health sector, as well as opportunities. Meanwhile, there is greater pressure on the government to foster awareness regarding prevention, especially considering that a growing population with aggravated health conditions will have an impact on the federal health budget. Changes in the General Health Law focused on tenders have pushed the industry to reimagine how to do business with the public sector.
Mexican companies and foreign players with operations in Mexico now face greater competition with the entry of low-cost medicines from Asian countries. However, new opportunities have also arisen for companies to develop innovative products and services that address Mexico’s changing needs.
The country's health and health sector do not depend on a single actor but on the sum of all industry participants. Mexico Health Summit 2019 provides decision-makers with an invaluable platform to discuss their perspectives on the future of the country’s health industry through constructive debate on key topics, combined with targeted and effective networking opportunities.
2019
Quick Look:
“Mexico Health Review has become increasingly relevant over the past five years as it gathers information from the sector's key leaders” El Financiero
INCLUDING: ∙∙ Alejandro Gil, Centro Médico Puerta de Hierro ∙∙ Macedonio Garza, Farmacias Benavides ∙∙ Américo García, Apotex ∙∙ Mario Muñiz, IQVIA
30 TOP SPEAKERS
∙∙ David Kershenobich, INCMNSZ ∙∙ Carlos Septién, Grupo Diagnóstico PROA ∙∙ Ana Longoria, Novartis ∙∙ Rodrigo Puga, Pfizer Mexico ∙∙ Miguel Salazar, AMIIF ∙∙ Jaime Cervantes, Vitalmex
TICKET PRICES FOR 2020
Super Early Bird Rate MX$12,000 + IVA (until 10/07/2020) Early Bird Rate MX$14,000 + IVA (until 07/08/2020) Conference Rate MX$16,000 + IVA (until 02/09/2020)
Get your 2020 tickets now: www.mexicobusinessevents.com
155 COMPANIES REPRESENTED
“Without a doubt, Mexico Health Summit has become one of the greatest summits of the sector” NotiPress
274 PARTICIPANTS
“In the industry, we are used to talking about patients, when we should be talking about people. Hospitals of the future will be health units focused on attending healthy people, rather than sick ones” José Elizondo, Founder of Wellmedic Health Centers
P R O GR A M 07:30 REGISTRATION 08:30
CANNABIS REGULATORY FRAMEWORK AND OPPORTUNITIES
Speaker:
Alejandro Luna, Partner litigation and Life Sciences Co-chair at Olivares
Ingrid Ortiz, Associate of Life Sciences at Olivares
09:15
RETHINKING THE HEALTHCARE SYSTEM AND THE ROLE OF ITS ACTORS
Moderator:
Jaime Castro, Director General of BPF Part of QBD Group in Mexico
Panelists:
Alejandro Gil, CEO of Centro Medico Puerta de Hierro
Macedonio Garza, Director General of Farmacias Benavides
Américo García, Director General of Mexico and Latin America at Apotex
Alejandro Paolini, Director General of Siemens Healthineers for Mexico, Central America and Caribbean
Ignacio Garcia-Tellez, Director of Health Sector of KPMG in Mexico
10:00
NETWORKING COFFEE BREAK
10:30
HEALTHCARE 4.0: REDEFINING HEALTH THROUGH TECHNOLOGY
Speaker:
Mario Muniz, Director General of IQVIA
11:00
THE PARADOX OF THE HEALTHCARE SUPPLY CHAIN
Moderator:
Marcos Pascual, Commercial Director of ANAFARMEX
Panelists:
José Elizondo, Founder of Wellmedic Health Centers
Anil Andrade, Director General of ACG Group
Eduardo Tapia, Director of Life Science and Health Care for DHL Supply Chain Mexico
11:45
NETWORKING COFFEE BREAK
12:15
THE FUTURE OF MEDICINE
Moderator:
Victor Saadia, Founder and CEO of BioCenter
Panelists:
Felipe Vadillo, Professor and Director of Research at INMEGEN
David Kershenobich, Director General of INCMNSZ
Diddier Prada, Researcher of Medical Sciencies at INCan
Laura Padierna, Director of Biological Applications at LEI
13:00
NETWORKING LUNCH
14:30
INNOVATION: KEY DRIVER FOR GROWTH AND COMPETITIVENESS
Moderator:
Eduardo Lara, Head of Health for RGA Latin America
Panelists:
Rodrigo Díaz de Vivar, Subregional Head of Management Center Latin America North and Country Manager of Roche Diabetes Care Mexico
Carlos Septién, Director General of Grupo Diagnósitico PROA
Ana Longoria, President and Director General of Novartis
Javier Potes, Director General of Consorcio Mexicano de Hospitales
15:15
PREVENTION AND EDUCATION TO IMPROVE HEALTH
Moderator:
Sandra Sánchez-Oldenhage, Director General of PharmAdvice
Panelists:
Mario Sicilia, Director General of Laboratorio Médico Polanco
Rodrigo Puga, President and Country Manager of Pfizer Mexico
César Carrasco, Country General Manager of Philips Mexico
Miguel Salazar, Member of the Board at AMIIF
16:00
NEW MODELS TO INCREASE ACCESS TO HEALTHCARE
Speaker:
Jaime Cervantes, CEO of Vitalmex
16:30
NETWORKING COCKTAIL
COMPA N Y AT T E N DA N C E ABCHospitales
Cámara Mexicano-Alemanade
Farmacias Benavides
ABSSeguros
Comercio e Industria (CAMEXA)
Farmacos Proasse
AccordFarma
CANIFARMA
FujiFilm
ACGGroup
Carestream Health
Fundación Dibujando Un Mañana
Advent International
Central de Productos Quimicos
FunSalud
Allergan
Centro Medico Dalinde
Galicia Abogados
AMEGI
CHG Meridian
Gamma Biolabs
Amgen
Chiesi
Genetics and Health
AMID
Chinoin
Genomma Lab
AMIIF
Colegio Nacional de Químicos
Glaxo Smith Kline
ANAFARMEX
Farmacéuticos
Global Health Intelligence
ANCAM
Biólogos México
Global Reach RX Mexico
Apotex
COMERCIALIZAORA MAVERO
Grupo Bruluart / Brudifarma
ArqMedyca
CONAMER
Grupo Diagnostico Proa / Chopo
Arroba Ingeniera
Consejo Mexicano Famacéutico
Grupo Horkest
ArTecnica
Consorcio Mexicano de Hospitales
Grupo Promass
Asesor Legal & Asociados
Corporate Wellness
Grupo Rasch
Atramat
DHL
Grupo Vitalmex
Avena Health
DiaSorin
Hacking Health
Balero
Dicipa
Happinss
Becton Dickinson
Dräger
Hermes Systems
Beneficiencia Española de la Laguna
DVA Mexicana
Hetero
BioCenter
Embajada de Canadá
Hogan Lovells
BioMérieux México
Embajada deI ndia
Hospital ABC
BioSkinCo
Embajada de los Países Bajos
Hospital Ginequito
BPF by QBD
Equipos Medicos Peninsulares
Hospital HMG
Bristol Myers
Essity
Hospital Puerta de Hierro
BUPA
Etrueba Distribuciones
Hospitaria
Business France
Farmaceuticas
Hubble Logistics
Business Sweden (Oficina comercial
Eurotrials
ICON
de la embajada de Suecia)
Farmacia Paris
INCMNSZ
Indukern Mexico
Marzam
Pierre Fabre
Infinite Clinical Research
Mayoly Spindler Mexico
PRAHEALTHSCIENCES
International
Médica Santa Carmen
Prescrypto
INMEGEN
Medico Puerta de Hierro
PrevemSeguros
Innovación en Logística y
Medistik
PWC
Distribución
Medix
Reinsurance Group of
Instituto Nacional de Neurología y
Mexglobal
America(RGA)
Neurocirugía
Micro Pharmaceuticals Mexico
RM Pharma Specialists
International Finance Corporation
Mindray
Roche
IQVIA
Miyabi Labs
Rossbach de Mexico
Janssen
Multivac
Sanatorio Durango
Keuhne+Nagel
Muralmed
SEMIOSFERA
Klockner Pentaplast
Novartis
Siemens Healthineers
Knaou
Novostrategia
Signufarma
KPMG
NTA Logistics
SisNova
Kronos
OCASA Logistics
SMEO
Kurago Biotek
Olivares & Cia
Sociedad Mexicana de Ingeniería
LEI
Olympus
Biomédica
LEO Pharma
Opti Max
TIBA
Linfolab
Oriundo
Trifermed CBDO
Liomont
PACONSULTING
Ultimate Médica
LOBSAN Health
Pen Healthcare
Validpro
MAG Medical
Pfizer
WellMedic
Malvern Instruments
Philips Healthcare
Yana
5 MEMBERS OF THE PRESS
497 VIEWS ON LIVESTREAM
Satisfaction Level
Most Valuable Elements
Satisfied 52% VeryDissatisfied Very satisfied 34% Satisfied 5% Neutral 2% Dissatisfied 7% Very Dissatisfied
Very Dissatisfied Satisfied
Neutral
of Topics Networking Networking Opportunities 20% Organization and Venue
11,009 TOTAL MINUTES VIEWED LIVESTREAM
26,600 IMPRESSIONS
47% and Relevance Organization Venue 33% Content
13,451 IMPRESSIONS
HIG HL I G HTS 201 9
KEY SPEAKER
GREEN GOLD RUSH LIMITED BY REGULATION Mexico has moved away from its prohibitional model but there are still gaps in the regulation of cannabis for medical, scientific, industrial and even recreational use. However, judicial rulings are pushing for clarity and expedited regulation, said Alejandro Luna, Partner Litigation and Life Sciences Co-chair at Olivares, during the opening presentation of Mexico Health Summit 2019, held on Thursday at Papalote Museo del Niño in Mexico City. “Cannabis products are present in the food, beverage, medicine and textile industries, to name a few. The combination of several factors, including the fight against drug
ALEJANDRO GIL
dealing and the medical benefits of cannabis, led many countries to adopt a new
CEO of Centro Medico
stance toward its use,” Luna said.
Puerta de Hierro Alejandro Gil is a healthcare consultant
In Mexico, change was also fueled by confrontations between people looking to
with proven experience in process
access cannabis-based medications and the authorities. Luna highlighted the case
improvement, business development
of Grace, a sick child whose parents were not allowed to import medicinal products
and hospital operations. Gil has worked
with cannabidiol. After Grace’s family presented an amparo against the country’s
for Centro Médico Puerta de Hierro in
prohibitive regulations, amendments were made to the General Health Law. “The
Guadalajara, Jalisco, for over eight
Supreme Court was the first to take a step toward a new regulation, even in terms
years. Previously, he was President of
of recreational use,” he said.
the Medical Tourism Cluster of Jalisco. Gil holds a Bachelor’s in industrial
The Supreme Court decided that the prohibition regarding cannabis use was
engineering from the Monterrey
unconstitutional. “The fundamental right to free personality development establishes
Institute of Technology and an MBA
that adults have the right to decide in which recreational activities they participate.
from the Thunderbird School of Global
This makes cannabis use an activity proper to the autonomy of each person, as long
Management in Arizona.
as it does not affect third parties,” Luna said Refusal from the san.itary regulator to analyze the import of a medicine based on cannabidiol opened the door to analyze the regulation. According to Ingrid Ortiz, Associate of Life Sciences at Olivares, in 2017 former President Enrique Peña Nieto presented an initiative to revise the General Health Law and the Federal Penal Code, although this was only focused on medicinal and scientific use. Changes included the regulation for cannabis use and cannabis-based products, as long as there was a permit from the Ministry of Health, permission to plant and grow cannabis plants and the possession of up to 5g of cannabis.
H I GH L I GH TS 2 019 “COFEPRIS established the guidelines regarding control of cannabis and derivates, which led to 62 approvals for products, including raw materials, food, supplements and medicine. However, in March 2019, these guidelines were revoked by COFEPRIS based on the argument that the guidelines surpassed medicinal and scientific use,” said Ortiz. Besides the revocation of permits, regulations are still unclear on how to obtain cannabis for consumption and manufacturing of cannabis-based products. Ortiz says today there are nine active initiatives to reform regulations, the last one presented only a month ago. Meanwhile, Luna highlighted the Supreme Court’s latest ruling established that, as of two weeks ago, COFEPRIS had a 180-day timeframe to develop a complete regulation that considered the sourcing, storage,
“Cannabis products are present in the food, beverage, medicine and textile industries, to name a few. The combination of several factors, including the fight against drug dealing and the medical benefits of cannabis, led many countries to adopt a new stance toward its use” Alejandro Luna, Partner litigation and Life Sciences Co-chair
distribution and commercialization of cannabis and cannabis-based products for medical and scientific use. “There are already companies wanting to participate in the growing cannabis industry but lack of regulation prevents proper business development. Today, there is a green gold rush in Mexico and the world and even though not everyone will become a millionaire, many will get rich by selling picks and shovels for those seeking gold,” he said.
KEY SPEAKER BOOST HEALTH ACCESS THROUGH INTEGRATIVE STRATEGIES, WILL TO IMPLEMENT THEM Increasing access to healthcare services is a common goal for many players in the sector, but individual areas are implementing their own strategy to address the problem. At Mexico Health Summit 2019 on Thursday, representatives from major areas of the sector discussed integrative strategies that can bring different players together to increase access to health. The panelists at Papalote Museo del Niño discussed the priorities that must be addressed if the country is to step closer to the elusive goal of achieving universal
MACEDONIO GARZA
care. The challenge is not simple. “Mexico has a complex epidemiological profile
Director General of
as it must treat infectious diseases that are more common to emerging economies
Farmacias Benavides
and non-communicable diseases that are more prevalent in richer countries,” said
Macedonio Garza is Director General
Americo García, Director General of Mexico and Latin America at Apotex.
of Farmacias Benavides, a member of the Walgreens Boots Alliance. Under
The common problem for the sector as a whole, however, is obvious but equally
his leadership, over 100 business units
difficult: money. Among all OECD countries, Mexico has the second-lowest
have been inaugurated in various states
investment in healthcare as a percentage of its GDP. “An essential issue to achieve
over the past 12 months. The company
universal care is financing,” said Ignacio García-Téllez, Director of Health Sector
has also developed complementary
of KPMG in Mexico.
services such as home delivery and primary healthcare consultations at
The problem will likely be exacerbated after recent budget cuts and regulatory
points of sale. Garza was a founding
changes that could further hurt an already fragmented system. Help could come
member of the WBA Group's Global
from beyond the government. “The federal budget for many areas including
Inclusion Council. Moreover, he holds a
healthcare is shrinking, so private industry can support the public sector,” said
MBA from IPADE Business School and a
Alejandro Gil, Director General of Centro Médico Puerta de Hierro. While public
Bachelor's from the Monterrey Institute
institutions provide care for most Mexicans, the quality and quantity of services
of Technology in electronic systems.
HIG HL I G HTS 201 9 they provide varies widely by institution. This has pushed many toward the private sector. Today, out of pocket expenditure surpasses 40 percent of the country’s total healthcare expenditure, a high number in comparison to other OECD countries. Moreover, only about 8 million Mexican have health insurance, a low number according to García-Téllez. While Gil supports the generation of public-private alliances (PPAs) to reduce spending and increase efficiency, Macedonio Garza, Director General of Farmacias Benavides, proposed a complementary strategy: “Doctors at the point of sale play an important role in increasing access to care, especially for primary care.” While partnerships with the public sector will benefit patients, alliances among players from different industries are also key. However, the spirit of collaboration must begin with players from the same segment. Gil explained this need in terms of his own industry. “Private hospitals need better integration because most operate individually.” Operating as partners instead of competitors can result in many benefits for hospitals and patients. “For instance, in the US, hospital groups can perform consolidated acquisitions that reduce costs and allow them to offer less expensive medications to patients. The panelists agreed that optimizing budgets was
“Doctors at the point of sale play an important role in increasing access to care, especially for primary care.”
a key element in allowing their segments to increase
Macedonio Garza, Director General of Farmacias Benavides
three pesos that would have been spent on treatment.
access. Alejandro Paolini, Director General of Siemens Healthineers for Mexico, Central America and Caribbean, took this idea one step further. “To increase the efficiency of the healthcare budget, it must be redirected toward prevention. Every peso spent on prevention saves Investing in prevention would allow for better results with the same budget.”
To implement these strategies, the sector needs a stable playing field to plan. “Mexico needs a clear regulatory framework that allows all players to put the patient at the center of attention,” said García. To achieve this, the sector needs an efficient regulator. “The regulator plays an essential role in the healthcare sector because it must balance protecting the patient’s health while ensuring they have access to innovative medications. A regulator that is too strong will limit access. A regulator that is too lax places the public at risk,” said Paolini. The entire healthcare sector requires a fundamental change that integrates the efforts from a diverse range of areas, from R&D to distribution. A tool that is touted for its benefits across sectors is technology. “Technology provides significant advances in many areas, including diagnostics, helping doctors to diagnose diseases faster and improve the patient’s life expectancy while reducing costs. In terms of treatment, technology can permit minimally invasive surgeries that turn procedures that required hospitalizations for five or six days in ambulatory care, greatly increasing the patient’s comfort and reducing hospitalization costs,” said Paolini.
H I GH L I GH TS 2 019 While panelists agreed that technology can increase efficiency across many sectors,
KEY SPEAKER
García pointed to an even more essential need. “What is necessary is not technology, but will. Mexican players need the will to work and collaborate to develop integrated strategies that benefit patients across the country.”
CHANGE IN MINDSET NEEDED TO UNLOCK TECHNOLOGICAL POTENTIAL Adoption of digital health tools could improve patient care and reduce treatment costs but a change in mindset is still required to make new technologies part of the mainstream, said Mario Muniz, Director General of IQVIA, at Mexico Health Summit 2019, held on Thursday at the Papalote Museo del Niño in Mexico City.
MARIO MUÑIZ Director General of IQVIA Mario Muniz has held several marketing,
“Boosting adoption of health apps to improve care for patients with diabetes, asthma,
sales and general management
pulmonary rehabilitation, cardiac rehabilitation and diabetes prevention could lead
roles and has worked with different
to savings of US$7 billion in the US,” said Muniz.
business models, from startups to large companies with regional operations in
According to Muniz, there are over 318,000 health-related apps globally and 200
Latin America. His areas of expertise
new ones are created every day. Moreover, 40 percent of all apps are oriented toward
include strategy and execution in
disease management rather than on wellness monitoring. “Companies are using apps
the pharmaceutical industry and
for insurance purposes, to follow up on treatments and register symptoms. In terms
medical technology in Latin America.
of diseases, 28 percent of all apps are focused on mental health and behavioral
Muniz holds a postgraduate degree
disorders, 16 percent on diabetes and 11 percent on heart disease,” he said.
from Harvard Business School, an MBA and postgraduate degree from
The innovative use of sensors has also helped apps track more indicators, including
Ohio University and SDA Bocconi,
calories, steps, heart rate and sleep patterns. “Sensors are now used for smart devices
and a Bachelor’s in strengths-based
focused on user experience, digital diagnostics with increased reliability and clinical
management from Bellevue University
trials with increased recruitment speed, more effective monitoring and follow-up,”
of Nebraska.
said Muniz. However, the number of apps appearing in the market means an increased offering for patients that does not always comply with basic quality standards. To tackle this
HIG HL I G HTS 201 9 issue, IQVIA released its AppScript Score Overview to measure the quality of apps based on different factors, including the patient, the app’s development and its capabilities in terms of disease management, wellness and prevention. Today, Muniz says 20 percent of health industry professionals use digital health tools, 26 percent of all physicians recommend digital apps and 13 percent use remote monitoring to follow up on patient development. In 10 years, Muniz expects digital health to become the new normal for most organizations. “There are still doubts regarding data security and the legal framework regarding digitalization. We also need electronic medical records and digital prescriptions to boost adoption of digital health tools. However, the main issue we need to tackle is mindset, both of companies and patients. A change in mindset will be the only way to take advantage of the potential of these tools,” he said.
THE PARADOX OF THE HEALTHCARE SUPPLY CHAIN Whether it is logistics, hospitals, pharmacies or technology companies, there is a shift toward putting people and their needs front and center in the healthcare industry, panelists said at Mexico Health Summit 2019, as they reflected on the paradox of the healthcare supply chain. “In the industry, we are used to talking about patients, when we should be talking about people. Hospitals of the future will be health units focused on attending healthy people, rather than sick ones,” said José Elizondo, Founder of Wellmedic Health Centers, during a summit discussion at the Museo Papalote del Niño in Mexico City on Thursday.
KEY SPEAKER Elizondo was joined by Marcos Pascual, Commercial Director of ANAFARMEX; Anil Andrade, Director General of ACG Group and Eduardo Tapia, Director of Life Science and Healthcare for DHL Supply Chain Mexico, to discuss how supply chain companies and hospitals are using technology to migrate to a model where needs of end-users are privileged and attended in a more efficient manner. Pascual said that the implementation of doctors’ offices at points of sale has generated further access to basic health services. “Doctors’ offices adjacent to pharmacies have been the private sector response to provide health coverage with certified doctors
DAVID KERSHENOBICH
and medications at accessible prices,” said Pascual. Elizondo acknowledged that
Director General of INCMNSZ
the implementation of these points of health services have allowed an improvement
David Kershenobich served for 30
in access to basic health attention but they do not solve the problem of access to
years as Head of the Clinical Service at
specialists. “During the past governmental administrations, we have seen investment
INCMNSZ. He has held other positions
destined to alleviate the health infrastructure problem. However, the paradox we are
at the Institute, including Teaching
seeing is related to human capital.”
Coordinator, member of the Ethics and Research Committee, Head of the
For Elizondo, in a country where only three out of 10 doctors have a specialty
Department of Gastroenterology and
degree or sub-specialty, telemedicine presents an interesting opportunity to
Member of the Board of Directors.
provide more coverage and to continue putting patients front and center. “The
Kershenobich has written 489
human capital deficit that exists in the country will only be solved through
publications, of which 201 are original
digitalization of health services,” he said.
articles, seven are books and 85 are book chapters. He is a surgeon and
Implementation of technology solutions and digitalization not only touches upon
studied medicine at UNAM. He holds
access to medical attention but also in the medication distribution and tracking
a Ph.D. in medicine from London
scheme. “Patients need to be able access medicines wherever they are. However,
University.
they need the certainty that the product they are consuming is not fake. In this sense,
H I GH L I GH TS 2 019 medicine tracking becomes vital,” said Andrade. “The use of aggregated data can help patients and guarantee them that their product is authentic.” In addition to guaranteeing product authenticity, Tapia mentioned that logistics companies have the responsibility of guaranteeing that medicines and medical devices they deliver are maintained in quality
“The human capital deficit that exists in the country will only be solved through digitalization of health service” José Elizondo, Founder of wellmedic Health Centers
conditions. “We are seeing how IoT can help us to obtain real-time information regarding the conditions of the medicine and allow us to implement better quality control.” Although companies are still far from implementing all the available technology solutions in the market, Tapia said that they are all going through a transformation process that aims to be more efficient and useful for patients. “In other countries, DHL even helps in the transport of patients. As a logistics company, we are working on finding the best way to put patients front and center.
THE FUTURE OF MEDICINE Chronic diseases continue to be the bane of developed economies. Mexico has an additional problem in the shape of infectious diseases, which still affect millions of individuals every year. While many strategies have been implemented to tackle these problems, the sector has not found a one size fits all solution. However, all sectors, each in their own way, is searching for the next treatment that might save a life. At Mexico Health Summit 2019, held at Papalote Museo del Niño on Thursday in Mexico City, panelists addressed relevant research lines that, in the near future, will address the problems of today. A pressing problem, agreed panelists, is identifying the problem on time. “Doctors arrive late; we only treat patients once they are sick,” said David Kershenobich, Director General of INCMNSZ. Preventing a disease is not just cheaper than treating it but it is overall better for the patient, who can avoid complex treatments, medications and surgeries. For that reason, many researchers are looking for better, faster and more precise diagnostic techniques. Luckily, there are tools to facilitate
HIG HL I G HTS 201 9 this. “Through the incorporation of the human genome map we will be able to develop innovative medical solutions,” said Felipe Vadillo, Professor and Director of Research at INMEGEN. Kershenobich agreed on the importance of new research lines in addressing diseases: “Another important area is research on the human microbiome, which will allow the generation of numerous treatments,” he said.
“We have to reach patients earlier through preventive medicine. New screening techniques can allow patients to know their susceptibility to certain diseases before they happen.” David Kershenobich, Director General of INCMNSZ
Current research is already bearing fruit. “Many treatments that we only dreamed about 10 years ago are now a reality. For instance, US hospitals can now perform liquid biopsies that allow for an easier and faster diagnosis,” said Diddier Prada, Researcher of Medical Sciences of INCan. Moreover, research can also help to prevent a disease altogether. “An interesting area is the development of psychological profiles to identify individuals who do not look after their own health. These profiles will allow doctors to develop better strategies to monitor them and entice them to improve their habits to have a better life,” said Prada.
An area where prevention will be key is chronic diseases, due to their complexity and the limited understanding of them. “Mexicans need to understand that chronic diseases have a complex nature. Even doctors still do not know how they fully work,” said Vadillo. Moreover, chronic diseases place a significant burden on patients and their families. “Chronic diseases force patients to take medications for their entire life,” said Laura Padierna, Director of Biological Applications at LEI. Padierna added that through genomic therapy it may be possible to cure instead of manage these diseases, and the panelists agreed that at this point preventing the disease is more viable. “We have to reach patients earlier through preventive medicine.
H I GH L I GH TS 2 019 New screening techniques can allow patients to know their susceptibility to certain diseases before they happen,” said Kershenobich. Prevention is not just the responsibility of the patient; doctors also play an essential role. “At schools, students are taught to treat diseases. They are provided few classes on preventive measures. Preventive medicine is more effective and less expensive than curative medicine but the country does not have a prevention culture,” said Prada. Victor Saadia, Founder and CEO of BioCenter, tackled one of Mexico’s biggest problems: the increasing prevalence of obesity. “Obesity and overweight are often multigenerational problems, as very often obese parents have obese children.” In that sense, innovation can also play an important role and even the private sector has taken notice. “About half of Silicon Valley companies address nutrition in one way or another,” said Kershenobich. “This concept is becoming increasingly important and companies are researching the production of better foods that allow individuals to live healthier lives. Mexico has a broad range of unique foods but the country is not taking advantage of this amazing variety.” While many potential treatments for chronic diseases are being researched at any given time, the importance of prevention has not received the same level of attention. “At this point there are no public programs that research the role of prevention in healthcare,” said Prada. However, its role will only become more importance with time. “Life expectancy is increasing in Mexico and the world, which implies an increasing number of seniors who will require continuous care and monitoring to maintain their quality of life,” said Prada.
KEY SPEAKER INNOVATION: KEY DRIVER FOR GROWTH AND COMPETITIVENESS Innovation makes no sense unless it is done with the patient at its center and focuses on problem resolution, panelists said as they reflected on the opportunities at the Mexico Health Summit 2019 at the Museo Papalote del Niño in Mexico City on Thursday. “The system has an inertia where patients are not front and center. We need to change attention models and innovate to make health services accessible to the overall population,” said Javier Potes, Director General of Consorcio Mexicano de
CARLOS SEPTIÉN
Hospitales, during the panel discussion.
Director General of Grupo Diagnósitico PROA
Potes was joined by Eduardo Lara, Head of Health for RGA Latin America; Rodrigo
Carlos Septién was Executive Director
Díaz de Vivar, Subregional Head of Management Center Latin America North and
of Grupo Elektra from 2007 to 2013
Country Manager of Roche Diabetes Care Mexico; Carlos Septién, CEO of Grupo
and of Banco Azteca from 2002 to
Diagnóstico Proa; and Ana Longoria, President and Director General of Novartis.
2013. Septién also has experience as
The panelists reflected on how there needs to be a coordination between the public
Vice President of Information and
and private sectors to make the newest and most innovative treatments accessible
Public Affairs at Grupo Salinas and was
to the overall population.
Chairman of the Board of Directors at Libertad Servicios Financieros. Grupo
For Longoria, the only way to make health technology and innovation accessible
Proa is a corporate group formed
is through a comprehensive integration of the health system. “We are seeing
by companies dedicated to clinical
older patients with chronic degenerative diseases, while the generation and
analysis and cabinet studies. Septién
commercialization of a new molecule can take up to 10 years of development and
holds a Bachelor’s from Iberoamerican
cost around US$1 billion. There is no single health system in the world that can face
University and a Master’s from Purdue
this challenge on its own.
University in Indiana.
HIG HL I G HTS 201 9 As part of the efforts that need to be implemented to make sure that patients have access to new technologies, Lara said that the industry needs to reimagine its cost model. “We need to start measuring and paying in terms of results of medical services. The worst way to pay for medical care is through a pay-per-service model.” Potes added that in this sense, hospitalization services need to be understood as a service. “We need to continue insisting on the financial and operational model.” For Septién, the main innovation challenge for laboratories lies in being able to differentiate and generate added value for patients and doctors and avoid being seen as a commodity. In this sense, Septién also emphasized the need to put prevention of chronic-degenerative diseases in the spotlight. “We need to move from a concept of curative medicine toward a prevention scheme. The lack of prevention entails more expenses in the long run.” As an example of how prevention can lead to cost reduction, Díaz de Vivar said that there are diseases such as diabetes that go beyond the mere medical scope and need to be addressed from an integral perspective. “With digital solutions, we can provide scalability to reach more patients and thus reduce costs.” To which Longoria added, “It is important to have a long-term vision and implement public-private partnerships, so we can reduce technology and innovation costs.”
KEY SPEAKER
COLLABORATION A VITAL STEP IN PREVENTION STRATEGY The impact of healthcare on a country’s economic development is undeniable. Yet, Mexico’s health model is still focused on a corrective rather than a preventive approach, said Sandra Sánchez-Oldenhage, Director General of PharmAdvice and moderator of the Prevention and Education to Improve Health panel at Mexico Health Summit 2019, held on Thursday at Papalote Museo del Niño in Mexico City. “Mexico invests 5.8 percent of its GDP in health when the average of the OECD is 9 percent. Meanwhile, absenteeism related to health issues has a significant
ANA LONGORIA
impact on manufacturing activities and revenue generation. Only in the automotive
President and Director
industry, productivity and results are hit by a 7.3 percent reduction,” said
General of Novartis
Sánchez-Oldenhage.
Ana Longoria has 15 years of experience at Novartis. She started her career
Prevention can save lives, according to Miguel Salazar, Member of the Board at AMIIF.
with the company in Spain as part of
However, it is normally seen as an added burden. “Just like with innovation, patients
the International Career Development
tend to see prevention as an added cost related to gyms or different eating habits.
Program in 2005. Subsequently, she
In reality, prevention is much more than that. A clinical test can improve a patient’s
assumed numerous responsibilities
quality of life if used at an early stage,” he said.
in the fields of marketing and sales. Today, Longoria is Director General
Mario Sicilia, Director General of Laboratorio Médico Polanco, highlighted that to
of Novartis México and President of
move from a model that cures sick people to one that targets patients before they get
AMIIF. She has a degree in business
sick, the main need is information. “Clinical data is generated each day but it is not
administration from Iberoamerican
used. We know people are going to get diabetes and yet, no one is doing anything
University and an MBA from ESADE
about it,” he said. Change will not be possible from the public or private sector
Business School in Spain.
alone. Collaboration is needed from both sides to ensure access to medical care
H I GH L I GH TS 2 019 and to push for preventive strategies. To boost penetration of prevention schemes,
KEY SPEAKER
however, “the different players in the sector need to justify the economic benefits of early disease detection,” said Sicilia. New business models will also be needed to maximize resource and infrastructure use. “In terms of resources, we need to recognize that Mexico does not invest enough in healthcare. Yet, investment in health is one of the best projects a country can undertake,” said Rodrigo Puga, President and Country Manager of Pfizer Mexico. César Carrasco, Country General Manager of Philips Mexico, said companies are gradually opening their business to democratize access to prevention schemes, with some of them destining their infrastructure and equipment to night-time tests
RODRIGO PUGA
to offer competitive costs without compromising normal activities. “Companies are
President and Country
also developing remote systems to take advantage of underutilized infrastructure
Manager of Pfizer Mexico
during downtimes,” said Carrasco.
Rodrigo Puga has over 19 years of experience leading highly productive
There are already communication channels to foster collaboration between the
teams and implementing new business
government and the private health sector. What the industry lacks is clarity in
models at Pfizer. He joined Pfizer in
how to implement the best strategies to improve the sector, according to Salazar.
1997 and from that date has held
Nevertheless, all panelists agreed that President Andrés Manuel López Obrador’s
numerous directorial positions at the
willingness to invest in prevention is something that should be celebrated. “As
company, including New Products
an industry, we need to find ways to collaborate in this goal,” said Puga. “At the
Planning Manager, and oversaw
pharmaceutical level, companies have a mandate toward prevention.”
the Cardiovascular Business Unit at Pfizer Chile. Puga was Director of the
Puga highlighted vaccination programs and the work that both private and public
Vaccines Business Unit and Finance
organizations are doing toward preventing teenage pregnancy as key elements
Director for Argentina, Uruguay and
where industry and government can collaborate toward prevention. “Vaccines are
Paraguay. In 2011 he was named
the most important prevention intervention,” he said. Meanwhile, Salazar pointed at
President and Director General of Pfizer
initiatives like Cumbia Camaleón as ways in which the industry can collaborate to
Peru and Bolivia. Puga has led Pfizer
create awareness. “Prevention campaigns can be another type of vaccine,” he said.
Mexico since 2016.
KEY SPEAKER
MERGE CAPABILITIES TO PROVIDE CARE About 68 million Mexicans, over 50 percent, do not have access to healthcare services. Addressing this problem has been the objective of many government administrations and organizations within the public and private sector. At Mexico Health Summit 2019, held at Papalote Museo del Niño on Thursday in Mexico City, Jaime Cervantes, CEO of Vitalmex proposed an integral strategy that will allow the public and private sector to work together to put the patient at the center of care. “Our healthcare system has made great strides in providing better care, but it is not enough,” said Cervantes. Mexico’s healthcare system aims to provide high-quality, affordable care to over 120 million people but this goal has not been achieved even
MIGUEL SALAZAR
though the country’s constitution states that healthcare is an essential right for all.
Member of the Board at AMIIF
The new administration further expands this goal as it aims to provide free medication
Miguel Salazar has more than 25 years
and healthcare services for all Mexicans through a focus on prevention.
of experience at Boehringer Ingelheim and has worked in the pharmaceutical
There are many barriers to access. Chief among them, explained Cervantes, is the
industry since 1988 in the US, Germany,
fragmentation of Mexico’s public healthcare sector. “There are 12 public providers
Mexico, Canada and the Caribbean. His
of healthcare and each has its own budget and rules.” Other hurdles are the high
academic and professional training in
operational costs associated with these institutions and the large number of
the technology and healthcare areas
intermediaries between patients and the industry. There is also a significant deficit
has allowed him to collaborate with
of doctors, nurses and specialists. The system is hampered further by poor-quality
leading companies, both local and
control of hospitals and the sector has not been able to provide electronic medical
multinational, such as McDonald's,
files. At this point, patients do not have access to their own medical information.
Bristol Myers Squibb and Boehringer Ingelheim. Salazar holds a Computing
The federal administration’s goal is to address these problems and provide primary
degree and a Master's in Management,
attention to all Mexicans through integrated healthcare networks. Cervantes explained
both from Anáhuac University.
that to bring together the public and private sector it is necessary to create mixed
H I GH L I GH TS 2 019 contracts that allow the optimal use of all hospitals and clinics within both sectors. “These contracts will allow the system to adapt to the patient instead of the other way around. While players in the sector often say that the patient must be empowered, Mexico’s healthcare system acts as a barrier to doing so. An example of poor allocation of resources is the
“While IMSS performs 3.22 surgeries per day, hospitals in the private sector perform on average 0.53 surgeries per day” Jaime cervantes, CEO of Vitalmex
distribution of surgeries across sectors. “While IMSS performs 3.22 surgeries per day, hospitals in the private sector perform on average 0.53 surgeries per day.” This problem, explained Cervantes, could be addressed through a mixed contract that would allow for better use of resources and to ensure that patients receive the care they need as soon as they need it. “These contracts must incorporate everything a patient might need from the moment they arrive at the hospital, from medical supplies to all hospital infrastructure.” The only thing that is necessary to implement these models is the will of the government and the industry. “A reform that will allow for the creation of mixed contracts will allow the provision of care for a larger number of Mexicans, which will be increasingly needed because by 2050 the country will have 150 million habitants. The government will not be able to care for this large population so it falls on us, the private sector, to ensure access to care.”
KEY SPEAKER
JAIME CERVANTES CEO of Vitalmex Jaime Cervantes has been CEO of Grupo Vitalmex since 2007. His lengthy career in the health sector includes many achievements. Among the most illustrative is having co-founded the Scientific Medical Committee for the research and development of the first Ventricular Assist Device in Latin America. Cervantes holds multiple diplomas and professional recognitions from prestigious institutions like IPADE, ITAM and the Monterrey Institute of Technology.
2020 SHERATON MARIA ISABEL MEXICO CITY SEPTEMBER 3, 2020
30
high-profile speakers
Mexico Health Summit is the industry’s premier event, bringing together key national and international players involved in the transformation of the country’s health industry. The summit provides an invaluable platform to present an insider’s perspective through constructive debate on key topics, combined with targeted and effective networking opportunities.
www.mexicobusinessevents.com/health
300
business and political leaders
Sponsorship Opportunities
Platinum Sponsor | US$18,500 Gold Sponsor | US$13,500
PRICES 2020
Silver Sponsor | US$9,500 Luncheon Sponsor | US$10,500 Networking Cocktail Sponsor | US$8,500 Seat Cover Sponsor | US$9,000 Coffee Break Sponsor | US$10,500 Charging Pole Sponsor | US$8,500 Speaker Room Sponsor | US$10,500 Wi-Fi Sponsor | US$8,500 Lanyard Sponsor | US$8,500
CONTACT
Live-Streaming Sponsor | US$5,000
Misael Oliver mo@mexicobusinessevents.com +52 55 5263 0221 Jorge Naupari jn@mexicobusinesspublishing.com +52 55 5263 0218
NETWORKING MATTERS. WE DO THE WORK. YOU GET THE RECOGNITION.
Our networking events, which are exclusively available to our top clients, are a must for C-level professionals who want to expand their business, improve their contacts or simply gain insights from other key stakeholders in their industry.
Networking Breakfast The ideal setting for a gathering of up to 25 industry executives to discuss key topics relevant to their sector while energy is high.
Networking Lunch An intimate working lunch with up to 20 sector leaders designed around a relevant discussion topic and sure to lead to new ideas and ventures.
Networking Cocktail A larger, evening event and the perfect opportunity to unwind over drinks and canapes. Our cocktails feature a VIP speaker invited to provide insight into a trending topic.
FOUR EXCLUSIVE NETWORKING COCKTAILS PER YEAR THE RIGHT AUDIENCE, THE RIGHT SPEAKER ONE BRAND. MAKE IT YOURS
Exclusive, by invitation only Network with the people and businesses that matter to you C-level participants Value-added opportunity to discuss trends and strategies Speaker presentations Topics and themes specific to your business segment
Exclusive Cocktail Sponsor
US$10,500 CONTACT
THIS IS HOW YOU BENEFIT:
ONE ELITE EVENT. TWO ELITE OPTIONS TO HIGHLIGHT YOUR BRAND. CALL NOW.
Misael Oliver mo@mexicobusinessevents.com +52 55 5263 0221 Jorge Naupari jn@mexicobusinesspublishing.com +52 55 5263 0218
2020 TA B L E O F C O N T E N T S
1
PARTICIPATE IN 2020 Mexico is carving out a place on the global health stage
YEAR IN REVIEW
with an increasing number of international companies choosing to set up Latin American headquarters in the
2
ACADEMIA & HEALTH PROFESSIONALS
3
HOSPITALS
4
MEDICAL TOURISM
5
FINANCING CARE
6
PHARMACIES & LABORATORIES
7
INNOVATIVE MEDICINES
8
GENERICS LABORATORIES
9
MEDICAL DEVICES
country and with its CROs fighting for a bigger slice of the clinical research pie. Mexico Health Review offers insight into the changes to the public system over the year, the mind-blowing innovations under development and the growth opportunities the industry presents.
10
MEDTECH
11
MANUFACTURING & SUPPLY CHAIN
12
LOGISTICS & DISTRIBUTION
13
LEGAL & CONSULTING
14
LOOKING AHEAD
3,000
COPIES
VISIT US ONLINE www.mexicobusinesspublishing.com/health
LET US WORK FOR YOU. CALL NOW TO PLACE AN AD
Providing unparalleled impact, Mexico Health Review is distributed to: Federal and state governments COFEPRIS, IMSS, ISSSTE, SNSP, CONACYT
Inside Cover Double Page | US$30,500
Primary industry associations and clusters
Double Page | US$20,500
Private and public hospitals and clinics
Table of Contents Page | US$25,500
Pharmaceutical and biotechnology leaders
Index Full Page | US$17,500 Full Page | US$14,500
Equipment suppliers and service providers
2/3 Page Premium | US$12,500 1/2 Page Vertical | US$10,500 1/2 Page Horizontal | US$10,500 1/3 Page | US$8,500
CONTACT:
Bookmark | US$22,500 Spotlight | US$10,000
Jorge Naupari jn@mexicobusinesspublishing.com +52 55 5263 0218
*20% surcharge for special positioning
Samanta Bonomo sb@mexicobusinesspublishing.com +52 55 5263 0239
| VIEW FRO
M THE TOP
A POWE RF AGAINST UL WARRIOR TO FIGHT A POWE RFUL EN EMY MENESES
ABELARDO
Director
VIEW FRO
M THE TOP
THE MUNICAB IMPACT OF ON HEAL LE DISEASES TH STAND ARDS
NONCOM
of Nation
al Institut e of Cancer
(INCan)
At the end of the 20 th century, epidem iologic Mexico underwent al transiti an on from DAVID KERS diseases. second pillar. infectio us Director As the country Meneses General HENOBICH to chronic says that of the Salvad ’s econom policies be prevent 40 percent y grew stronge or Zubirá implemented ed by simply of tumors Medical n Nation r, public by the govern Sciences modifying can al deaths due one of the and Nutritio lifestyles. 242 ment helped four major to infectio “Today, cancer n Institut reduce causes of n. Life expecta Q: What e is death. Tobacco challenges high-calorie are the institut ncy increas appeared. diets, exposur consumption, ed and new e’s prioritie According in Mexico e to cancer s for the were 131.5 rays and to the OECD, ? agents, exposur health sector lack of physica cases of in 2012 there cancer per e to UV l activity A: The institut percent while INEGI says Menese 100,000 are the major control of e’s main people in s. Tobacc data show their disease contributors,” focus Mexico o use is respons chronic return to that about is on noncom . After this malignant cancer tumors diseases, their own 70,000 people ible for one-thi period, they munica ble tumors every specialist based on and 16,000 rd of all to follow die of a mostly of over 18 annual cancer year. To up on their deaths and of tobacc adult popula years of reduce the deaths. “The treatment. o on health health expend age. tion number The most impact spending treat are Q: What of itures related common organizations billion, while research diabetes is approx diseases to chronic topics is and neopla imately the governm like the Nationa we diseases, the institut MX$61 These topics stic formati A: We are ent’s return l Institute believe on Produc e focused trying to ons, or cancer. are related from the preven tion of Cancer tion and on? understand Special Tax to our medica Services (INCan) is a key but they the develop the role (IEPS) on strateg y the new totals just l science are also ment of of genetic tobacco when addres s activitie medica l MX$38 billion.” closely intertw noncommunica consumption s in s profile of sing objectives. Inheritance ined with ble chronic particularly the Mexica Nutrition is not always our nutritio diseases. cancer. n popula can directly nal the predom tion, of noncom also the epigene impact the inant factor; Early diagno municable development tic factor, there is sis, the second chronic disease which refers is conditio to underst s. strategy, “To deal to the environ One of our colon, cervix ns that can and the with this is vital for priorities affect the mental role nutritio and prostat emergency, breast, and in the way a gene leads our n plays in e cancer we lean on the adminis commo n creation research expresses. these ailment , some of two pillars. cancer s tration of of public into social This the most s among health a nationa First, and issues that plans. lifestyles. Mexica ns, know the WHO. In l registry include habits We are conduc accord ing that allows Mexico, real penetra 70 percen to the us to tion of cancer Q: Where Nutrigenomic ting several t of patient second, disease s does the studies at in the country Institute the execut are already institute s with the to chronic dedicate ion of a understand in an advanc and A: We opened impacts most of its national prevention finally visit the express how nourish ed stage the Integra plan that resources? strategies, a healthc ion of certain ment when they includes l Attention are facility. early diagnos Patients genes. Center for palliative has opened (CAIPaDi) In respon is, access care and Diabetes se, the institut to promot diagnostic to treatme rehabilitation,” e preven patients. Another and preven nt, e Director it also organiz tion among At this center focus of says Abelard tion clinics. of INCan. our researc those es a ‘Cance o Menese we only Each year, h is on the received microbiota. attend patient s, rathon’ to are open their diagnos study of We have raise funds. s who have to everyo human approximately is within Clinics ne and offer 20 in our bodies, five years. 2kg of bacteri provide For years, subsequently to 60-min Doctors a diagno which means ute consult INCan had a genes usually sent to the sis that we have ations and sought the return after proper human is health institut cancer registry patient more bacteri ask the patient three months creation genes. We is registe ion at which a than of a nationa to record , which does to red. All are just a prevent how microb the l pathologies starting each new not serve The new clinics are ion culture. iota interact to underst cancer diagno to develop diagnosed regulat ion covered We propos and s with the by Seguro in the was finally patient sis. e six-hour individual. s can receive 2017. Three Popular not belong implem ented sessions if the patient to a health the results types of where in June does record s of their analyse consultations provider. the histopa are kept: from expert s, along with hospita l tholog ical nutritionists, data, The Salvado dentists, study perform depart ments In additio chiropodists ophthalmolog r Zubirán ed by patholo n to the National and trainers and a popula ists, national Medical have four Institute gy . In four months cancer registry tion-ba sed Sciences that reflects program is a public consultations, and Nutritio , INCan is , patients cancer registr health center and its integra the country which allows n committed research specializ ’s situatio y l to improv public and oncologists ed in treatme of noncom them to n. “All institut ing the numbe private, must have 90 municab available nt and ions, both le chronic in the country promoting r of report each diseases registry requires practitioners. quality medical , and educati case diagnos . It is aimed According the commit ng general care at ed. The to Menese ment of the governments 1,781 cancer s, in 2016, state and specialists and the first there were municipal in Mexico city to host Meneses. five , when there times that it was Merida, The project amount should be ” says was born to achieve parties, but INCan is with the complete lobbying| ANALY support now it will coverag the Senate, of third SIS receive e. Congress federal Health and a budget govern ment. and the Ministry allocated Public Educat by the Follow ing ion to make of registry at all medica Merida ’s oncology was launche examp l, odonto mandat le, d in Guadal logy and the ory online in takes almost nursing facultie ajara and Nuevo Leon will soon seven months s. “Today come and Baja it from the California. hospital patient’s until diagnos arrival at is.” the INCan expects When President Universal the registry Health led Enrique Peña by the Ministry to improv Programa The institut Nieto took to work toward Sectorial Health of Health. e the impact office almost Integral ion is also Within the universal Program 2013-2018, six years ago, de Preven of the clear example takinghas healthcare system would steps Juan stated been he promised , an elusive is vaccination (Integral ción y Contro treatment chasing for toward that this be achieved goal the Mexican . For over 40 Program innovat of cancer. years. dedicated by strengtheni l de Cáncer years we have ionAs for Cancer prepares to the cooperation to vaccinating health sector “We acquire in President ng regulators the been -elect Andrés Control and the population. August 2017, office, challenge among different and d a take Manuel López or congenital cyclotr There is no sectors. This Prevention), s old and added, would the institut on and since rubella in Mexico, rubella Obrador system, she new await also focus e has had its we have controlled and tetanus on providing production 14 The responsibi an area focused primary care, and neonatal diphtheria services based of solution lities of Mexico’s generating tetanus has on and managing on been eliminated,” told Mexico s for substantial the Ministry diagnosis and promoting Health Review appropriate of Health Narro . The institution budgets and scientific research. are 2017. treatme activity. Other must 127 million nt."look after the health risk factors individuals
|
243
THE GHOSTS OF HEALTHC PAST, PRE ARE SENT AND FUTURE
she identified of while leading tobacco, alcohol were unsafe on healthcare all national and illegal sex, matters, coordinatin policy drugs consumptio of road and the National g institutions n and lack workplace Health Service safety. Juan within main problems also identified and managing infrastructu that hindered three all healthcare re, among the state’s many other access to care. ability to provide tasks. Even ministry has The first was though the a lot on its the current plate, its current focused on model of healthcare, further, with curing diseases vision goes an ultimate instead of even objective to second was preventing healthcare implement the lack of them. The a universal system that implementa provides tion of multidiscipl public policies equal, sustainable integral attention that involve inary different institutions; to all individuals, and would be placing special on vulnerable necessary to do so it to guarantee attention groups. an between state efficient coordinatio and federal n strategies to permeated ensure that Mercedes the action healthcare Juan López, plans of other who was appointed sectors. Finally, challenge by Peña Nieto was the unequal the third Minister of in December Health benefits and fragmented 2012, set this the participatio when she , vertically as her main n of was named integrated goal to the position. institutions went directly that, she said, all Mexicans “Peña Nieto against the and medical asks that purposes of an inclusive professiona and prohibited effective ls commit country the provision the right to making of continuous to healthcare individual’s care through protection during her entire life. an ,” Juan said inauguratio n speech. This was achieve an necessary inclusive Mexico “to To address without poverty consolidatio these challenges through the n and creation , Peña Nieto’s Developme of effective to developmen nt Plan 2013-2018 programs National that lead t and equality included a for healthcare, in the country.” set of six objectives her administrat clearly delineated Juan stated ion would that in the Ministry work toward Sectorial access to basic Health Program providing all of Health’s Mexicans and specialty 2013-2018. consolidate care, including The first all actions was to surgeries. related to health and disease protection When delineating prevention. and health The second the strategy was to guarantee to quality to achieve mentioned healthcare access this goal, the challenges services to Juan all people. of overcoming to focus on The third epidemiolo reducing the Mexico’s changing was gical profile infant mortality caused by was to close rate. The fourth an aging population unhealthy healthcare habits, such gaps across and as bad nutrition social groups. was to guarantee and lack of The fifth the efficient physical use of healthcare and the sixth resources was to work toward a National System of
| PROJECT SPOTLIGHT
80
OF MEXICAN SUBSIDIARY PROVIDES EUROPEAN GROUP PATIENT COMFORT understands elderly patient at home Anyone caring for an to the mobility, nutritional the challenge of adapting Medical bedsthat must be met. and medical needs (Wi-bo) and Linet manufacturer wissner-bosserhoff this niche with electrically Group SE are addressing comfort. maximize the user’s adjustable beds that the bed’s height caretaker to adjust Allowing the user or can breathe of benefits. Patients provides a number with in bed or chat comfortably better, have breakfast support for The beds also provide caretakers. or visitors with the height adjustments, the knees which, together ulcers. The distribution to prevent allow for better weight it safer and be adjusted to make bed’s height can also to get in and out. easier for the patient
mattress that equipped with a firm Wi-bo’s beds are also lesions. weight to prevent skin supports and distributes facilitate sponge waterproof cover to They also employ a with wheels The beds are equipped baths and cleaning. safety once and brakes for increased to improve mobility adaptable bed the incorporation of parked. Furthermore, These railings also comfort and safety. railings grants both alongside the patient when walking provide support for according can also be adjusted the bed. The bed railings adjusted for seated and can be to user’s height when four different heights. wide, these 208cm long per 106cm With dimensions of also designed to up 270kg. The bed is beds can safely hold surface when necessary. Its be easy to extend horizontally both horizontal comes equipped with is easy to clean and accidents. bumper, to prevent and vertical corner a night light be equipped with Wi-bo beds can also the darkness that user find their way in function to help the This handset and off with a handset. can be switched on between three or caretaker to choose also allows the user mode. resident and locking safety levels: nursing,
and distributes a large Linet Group also manufactures furnishing mattresses, chairs and number of beds, tables, the patient’s and home care, all with concepts for hospital in the design company specializes comfort in mind. The the physical care by reducing of beds that facilitate efficiency. and improving their demands on caretakers that specializes is a German company wissner-bosserhoff chairs. of beds and transport in the manufacture
81
During his These goals years in office, were ambitious Narro prioritized diseases as at the time fighting chronic be so despite the way to and they continue the progress improve care. to made on several our highest “Diabetes Peña Nieto priorities, is one of fronts. Among administrati but it is difficult the on’s achievemen most important to tell which COFEPRIS, ts were strengthenin because there is the Mexico’s regulatory are many, g heart disease. such as cancer authority medical devices, When speaking for medication and foodstuffs of priorities, s, diabetes because and cosmetics, I often speak other products. it generates among many of This council the most deaths cause. Cardiovascu helped increase through the as a single access to lar disease approval of care may cause 540 generic grouped together more deaths patented versions of when but the causes medicines, previouslywhich allowed are many and into three to 70 percent can be split main groups: the reduction in the price heart attacks, of up others,” said of drugs. hypertensio penetration Moreover, Narro. n and healthcare expanded during that time. 78.6 percent While in 2012 of the population only Although had health the Ministry public healthcare coverage from of Health institution, a made several contribution by 2016 almost the population significant s to improve 86.6 percent was affiliated quality of of life and life during Peña to a system or Seguro expectancy such as IMSS, Nieto’s time Popular, according ISSSTE in office, the several areas to ENSANUT administrat that will be ion left 2016. addressed during López presidency NARRO TAKES . “Peña Nieto’s Obrador’s THE HELM administrat creation of ion has driven Juan left the a universal the health system. Ministry of Health in down with We now need 2016 and by José Narro, IMSS and ISSSTE to sit was replaced a surgeon and figure will allow us out a common from UNAM communita to easily exchange with a master’s tab that rian medicine in services and from the University of Seguro allow affiliates and who Popular to of Birmingham continued go to IMSS her legacy. or ISSSTE Antonio Chemor, While coordinatin facilities,” Joint Session National Commission says with the National g the er of Seguro School of Narro named Popular. Medicine in as some of 2018, Furthermore the main administrati achieveme , the rate of on the reduction nts of the diabetes, chronic continues of HIV transmission diseases and to child by to rise while obesity from mother 40 percent, the sector has also had maternal smaller healthcare mortality to deal with and dengue budget that by 13 percent a by 70 percent made Mexico investors in between 2012 one of the achievemen healthcare lowest and 2018. ts, he said, in the OECD. Other included the López Obrador On Aug. 9, introduction vaccine to a day after was officially protect girls of the HPV named President-e from cervical called for cancer. “This been lucky the future lect, Narro governmen country has with public t to increase policy in several expenditure its healthcare we would programs, and to tackle not have been otherwise obesity-rela able to achieve at the LV Ophthalmo ted diseases. Speaking what we have. logy Actualizatio A n Course in Narro was frank: “We Mexico City, have a very serious problem,” he said.
15